Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption

Clinical Endocrinology
J Pfeilschifter, R Ziegler

Abstract

Smoking has been associated with an increased incidence of endocrine ophthalmopathy (EO). In this study we examined the relation between smoking severity and the incidence of EO symptoms in patients with Graves' hyperthyroidism. Patients were prospectively followed for at least one year after the onset of hyperthyroidism. Smoking and EO status were evaluated at 3-6- months intervals. Two hundred and fifty-three ambulatory patients with recent onset of Graves' hyperthyroidism were studied. The incidence of total EO symptoms, proptosis, and diplopia at any time point before and after the occurrence of Graves' hyperthyroidism was assessed by interview and physical examination. Smoking was associated with a 1.3-fold increase in the overall incidence of symptomatic EO, and a 2.6 and 3.1-fold increase in the incidence of proptosis and diplopia, respectively. The relative risk increased in parallel with the current number of cigarettes smoked per day. In contrast, lifetime tobacco use was not an independent risk factor for the development of EO symptoms. Former smokers had a significantly lower risk for the occurrence of proptosis and diplopia than active smokers with a comparable lifetime cigarette consumption. Our data suggest that ...Continue Reading

Citations

Aug 14, 2003·Current Neurology and Neuroscience Reports·Kimberly P CockerhamEllen E Browne
Feb 23, 2012·Current Neurology and Neuroscience Reports·Erin F GillespieRaymond S Douglas
Jun 23, 1998·Survey of Ophthalmology·Y SolbergM Belkin
Oct 27, 1998·Clinics in Dermatology·Y Skurnik, Y Shoenfeld
Apr 9, 1998·Baillière's Clinical Endocrinology and Metabolism·A E Heufelder
Aug 7, 2002·Trends in Endocrinology and Metabolism : TEM·Wilmar M Wiersinga, Mark F Prummel
Apr 25, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Wilmar M Wiersinga
Mar 6, 2002·Clinical and Experimental Immunology·M Ludgate, G Baker
Mar 7, 2009·The New England Journal of Medicine·Luigi Bartalena, Maria Laura Tanda
Feb 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Peter VestergaardLeif Mosekilde
Dec 19, 2002·Thyroid : Official Journal of the American Thyroid Association·Wilmar M Wiersinga, Luigi Bartalena
Jun 12, 1998·Thyroid : Official Journal of the American Thyroid Association·J H Lazarus
Mar 9, 2005·Thyroid : Official Journal of the American Thyroid Association·Zsolt Szucs-FarkasEndre V Nagy
Nov 18, 2008·Thyroid : Official Journal of the American Thyroid Association·Shueh Lin LimAmir S Khir
May 29, 2003·The British Journal of Ophthalmology·A EcksteinJ Esser
Jan 1, 2009·International Journal of General Medicine·Gregory J Griepentrog, James A Garrity
Nov 10, 2009·Clinical Ophthalmology·Erick D BothunMichael S Lee
May 29, 2004·Journal of Endocrinological Investigation·L HegediüsP Vestergaard
Aug 4, 2005·Journal of Endocrinological Investigation·L BartalenaA Pinchera
Apr 23, 2011·Thyroid : Official Journal of the American Thyroid Association·Rebecca S Bahn ChairUNKNOWN American Association of Clinical Endocrinologists
Jun 11, 2014·Journal of Endocrinological Investigation·Luigi Bartalena, Vahab Fatourechi
Aug 15, 2014·International Journal of Genomics·Pengfei DuChangjiang Wang
Dec 3, 2014·Indian Journal of Ophthalmology·Eric S Ahn, Prem S Subramanian
Mar 13, 2014·Ophthalmic Plastic and Reconstructive Surgery·Matthew R EdmundsOmar M Durrani
Apr 13, 2010·Der Internist·A Eckstein, J Esser
Feb 11, 2009·Current Medical Research and Opinion·Ivan Berlin
Jan 24, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I Strempel
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Peter J Dolman
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Luigi Bartalena
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Morgan Yang, Petros Perros
Mar 27, 2012·The Medical Clinics of North America·Marius N StanRebecca S Bahn
Aug 9, 2011·Otolaryngologic Clinics of North America·Dan RobinsonRaymond Sacks
Jul 20, 2010·Neurologic Clinics·Kimberly P Cockerham, Stephanie S Chan
Jan 1, 2010·Journal of Autoimmunity·Yoav ArnsonHoward Amital
Jul 19, 2008·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Kwai Mei Law, George C Woo
Apr 16, 2013·Clinical Endocrinology·Wilmar M Wiersinga
Oct 7, 2004·The Medical Clinics of North America·Antara Mallampalli, Kalpalatha K Guntupalli
Sep 20, 2005·Orbit·Wilmar M Wiersinga
Jul 30, 2015·International Journal of Endocrinology·Yasuhiro Takahashi, Hirohiko Kakizaki
Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Aug 20, 2016·Eye·A Sadeghi-TariK Ameli Zamani
Mar 31, 2018·Military Medical Research·Md Saddam Hussain, Vishwas Tripathi
Jun 29, 2018·Ophthalmic Plastic and Reconstructive Surgery·Peter J Dolman
May 8, 2009·Nature Reviews. Endocrinology·Petros Perros, Gerasimos E Krassas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.